The Role of the Mineralocorticoid Receptor and Mineralocorticoid Receptor–Directed Therapies in Hear...
The Role of the Mineralocorticoid Receptor and Mineralocorticoid Receptor–Directed Therapies in Heart Failure
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Mineralocorticoid receptor (MR) antagonists (MRA), also referred to as aldosterone blockers, are now well-recognized for their clinical benefit in patients who have heart failure (HF) with reduced ejection fraction (HFrEF). Recent studies have also shown MRA can improve outcomes in patients with HFpEF, where the ejection fraction is preserved but l...
Alternative Titles
Full title
The Role of the Mineralocorticoid Receptor and Mineralocorticoid Receptor–Directed Therapies in Heart Failure
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2534610039
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2534610039
Other Identifiers
ISSN
0013-7227
E-ISSN
1945-7170
DOI
10.1210/endocr/bqab105
